Celgene (NASDAQ:CELG)

research

Biotech Short Sellers Run for Cover

The short interest data are out for the most recent settlement date, December 30. Generally speaking, companies within the biotech industry are considered to have a riskier group of stocks, ...
Read Full Story »
Test tubes

Jefferies Has 5 Top Biotech Stocks to Buy for 2017

Needless to say, the past two years have been rough on biotech. So rough in fact, that a basket of the largest capitalization stocks now trades with a price-to-earnings growth ...
Read Full Story »
biotech word cloud

Biotech Short Interest Sinks

The short interest data are out for the most recent settlement date, December 15. Generally speaking, companies within the biotech industry are considered to have a riskier group of stocks, ...
Read Full Story »
choose happiness

RBC Likes Large Cap Biotech Leaders for 2017

After a very poor 2016 for the biotechs, some on Wall Street are beginning to think that the light at the end of the tunnel may not be another train ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: Amgen, American Express, American Water Works, Celgene, Square and More

Stocks hit all-time highs last week, but the Dow Jones Industrial Average remained about 100 points under the elusive 20,000 mark on Tuesday. As 2016 comes to an end, the ...
Read Full Story »
biotech word cloud

Biotech Short Interest Remains Mixed

The short interest data are out for the most recent settlement date, November 30. Generally speaking, companies within the biotech industry are considered to have a riskier group of stocks, ...
Read Full Story »
buy sell stocks

Top Analyst Upgrades and Downgrades: AK Steel, Celgene, Darden, Delphi Automotive, Johnson & Johnson, US Steel and More

Monday brought a much needed sell-off after two and half weeks of almost constant rallying, but the sell-off was minimal. Tuesday's opening indication on the S&P 500 and Dow is ...
Read Full Story »
biotech word cloud

Short Sellers Grow More Aggressive on Major Biotechs

The short interest data are out for the most recent settlement date, November 15. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »
biotech word cloud

Short Sellers Grow More Selective on Major Biotechs

The short interest data are out for the most recent settlement date, October 31. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »
biotech word cloud

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The short interest data are out for the most recent settlement date, October 14. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »
biotech word cloud

Top Health Care Earnings Coming Next Week

Earnings season is now in full swing, and we have put together a preview of some of the world’s largest players in the health care sector. This current quarter ahead ...
Read Full Story »
graph

Mega-Cap Biotechs Cheapest in Years: 4 to Buy for 2017 Gains

It’s a tired refrain, as we have written about it for over a year, but the beating that the health care sector has taken, especially the biotechs, may be providing ...
Read Full Story »
Money and plant

Top Biotech Plays Highlight Jefferies Growth Stocks to Buy

More and more, the companies that we cover on Wall Street are starting to agree that while the future's still bright for the U.S. economy, it may be one of growth ...
Read Full Story »
biotech word cloud

Short Sellers Have Mixed Views on Major Biotechs

The short interest data are out for the most recent settlement date, September 30. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »
Pills and tablets

Big Pharma and Top Biotechs Highlight Jefferies Stocks to Buy Now

For the last year, many of the top pharmaceutical and biotech stocks have been under pressure from comments made by politicians looking to whip up voter enthusiasm. Recent issues over ...
Read Full Story »